Skip to main content
. 2022 Jul 15;13:898326. doi: 10.3389/fpsyg.2022.898326

TABLE 1.

Baseline characteristics for all patients and subgroup of patients at high risk for postoperative nausea and vomiting, defined by pre-operative Apfel-score of 3 or 4.

All patients (n = 385) Patients at high risk for PONV1 (n = 180)


Intervention group (n = 191) Control group (n = 194) p Intervention group (n = 87) Control group (n = 93) p
Age (years), median (IQR) 52 (43–62) 54 (46–62) 0.241 52 (43–62) 53 (46–61) 0.708
Female sex, n (%) 115 (60.2) 110 (56.7) 0.484 73 (83.9) 71 (76.3) 0.205
Pre-operative score results, median (IQR)
   Apfel score2 2 (2–3) 2 (2–3) 0.688 3 (3–3) 3 (3–3) 0.683
   HGSHS-53 1 (0–3) 1 (0–3) 0.798 2 (0–4) 1 (0–3) 0.483
   STAI-S4 41 (33–51) 40 (33–50) 0.478 43 (33–52) 44 (34–53) 0.937
   NRS5 0 (0–1) 0 (0–2) 0.308 0 (0–0) 0 (0–0) 0.396
Type of surgery, n (%)
   Intra-abdominal6 61 (31.9) 77 (39.7) 0.489 20 (23.0) 32 (34.4) 0.040
   Thyroid gland 36 (18.8) 30 (15.5) 24 (27.6) 16 (17.2)
   Gynecological7 24 (12.6) 15 (17.7) 21 (24.1) 11 (11.8)
   Urogenital8 21 (11.0) 26 (13.4) 5 (5.7) 12 (12.9)
   Other9 49 (25.7) 46 (13.7) 17 (19.6) 22 (23.7)
   Duration of surgery (min), median (IQR) 95 (69–140) 106 (74–141) 0.144 91 (68–128) 113 (74–135) 0.113
Intra-operative drug use
   Fentanyl (mg)10, median (IQR) 0.5 (0.4–0.5) 0.5 (0.5–0.6) 0.148 0.5 (0.4–0.5) 0.5 (0.4–0.6) 0.210
   Sufentanil (μg)11, median (IQR) 50 (40–64) 50 (40–70) 0.232 50 (39–60) 50 (40–62) 0.494
   PONV prophylaxis12, n (%) 94 (49.2) 99 (51.0) 0.722 55 (63.2) 61 (65.6) 0.740

1High risk for postoperative nausea and vomiting (PONV) is defined by a pre-operative Apfel score of 3 or 4 points. 2Apfel score: Apfel score of risk for postoperative nausea and vomiting (0–4). 3HGSHS-5: 5-item version of Harvard Group Scale for Hypnotic Susceptibility (0–5). 4STAI-S: State Trait Anxiety Inventory Scale (20–80). 5NRS: numeric rating scale of pain (0–10). 6Inter alia gastric surgery, colorectal surgery, hepatic surgery, cholecystectomy.7Inter alia hysterectomy, ovariectomy, pelvic floor repair.8Inter alia prostatectomy, bladder surgery. 9Inter alia herniated intervertebral disc, lumbar spinal stenosis, adrenalectomy, plastic/reconstructive surgery. 10n = 85/93 (intervention/control group) for all patients and n = 47/50 (intervention/control group) for patients at risk for PONV. 11n = 106/101 (intervention/control group) for all patients and n = 40/43 (intervention/control group) for patients at risk for PONV. 12Intraoperative, preventive medication against postoperative nausea and vomiting (PONV) with ondansetron, dexamethasone, droperidol, metoclopramide, dimenhydrinate, or a combination according to local protocols of each study site. The following missing data were excluded from the analysis: 109/67 cases missing (all patients/patients at risk for PONV) for preoperative HGSHS-5 score.